Clinical and histopathological characteristics in relation to aetiological risk factors in cutaneous melanoma: A population-based study

Melanoma Research

Volumn 9, Issue 2, 1999, Pages 189-197

  Masback A ^a   Westerdahl, J ^a   Ingvar, C ^a   Olsson, H ^a   Jonsson, N ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Aetiology; Hereditary; Histology; Melanoma; Risk factor

Indexed keywords

ADOLESCENT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; OCCUPATIONAL EXPOSURE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SUNBURN; SWEDEN;

EID: 0032812550     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199904000-00012     Document Type: Article

References (32)

1. Devesa SS, Silverman DT, Young LJ Jr, et al. Cancer incidence and mortality trends among whites in the United States, 1947 84. J Natl Cancer Inst 1987; 79: 701-770.
2. Magnus K. The Nordic Profile of skin cancer incidence: a comparative epidemiological study of the three main types of skin cancer. Int J Cancer 1991; 47: 12-19.
3. Magnus K. Incidence of malignant melanoma of the skin in the five Nordic countries: significance of solar radiation. Int J Cancer 1977; 20: 477-485.
4. McLeod GR, Davies NC, Little JH, et al. Melanoma in Queensland, Australia: experience of the Queensland Melanoma Project. In: Balch CM, Milton GW, eds. Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide, 1st edn. Philadelphia: JB Lippincott, 1985: 379-389.
5. Österlind A, Tucker MA, Stone BJ, et al. The Danish case-control study of cutaneous malignant melanoma. II. Importance of UV-light exposure. Int J Cancer 1988; 42: 319-324.
6. Beitner H, Norell SE, Ringhorg U, et al. Malignant melanoma: aetiological importance of individual pigmentation and sun exposure. Br J Dermatol 1990; 122: 43-51.
7. Grange F, Chompret A, Guillod-Bataille M, et al. Comparison between familial and nonfamilial melanoma in France. Arch Dermatol 1995; 131: 1154-1159.
8. Österlind A, Tucker MA, Hou-Jensen K, et al. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer 1988; 42: 200-206.
9. Elwood JM, Gallagher RP, Hill GB, et al. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada Melanoma Study. BMJ 1984; 288: 99-102.
10. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984; 72: 257-266.
11. Green A, MacLennan R, Siskind V. Common acquired naevi and the risk of malignant melanoma. Int J Cancer 1985; 35: 297-300.
12. Ford D, Bliss JM, Swerdlow AJ, et al. Risk of cutaneous melanoma associated with a family history of the disease. Int J Cancer 1995; 62: 377-381.
13. Westerdahl J, Olsson H, Måsbäck A, et al. Is the use of sunscreens a risk factor for malignant melanoma? Melanoma Res 1995; 5: 59-65.
14. Westerdahl J, Olsson H, Ingvar C. At what age do sunburn episodes play a crucial role for the development of malignant melanoma? Eur J Cancer 1994; 30A: 1.647-1654.
15. Westerdahl J, Olsson H, Måsbäck A, et al. Use of sunbeds and sunlamps and malignant melanoma in southern Sweden. Am J Epidemiol 1994; 140: 691-699.
16. Clark WH, From L, Bernardino EA, et al. The histogenesis and biologic behavior of primary human malig nant melanomas of the skin. Cancer Res 1969; 29: 705-726.
17. Arrington JH III, Reed RJ, Ichinose H, et al. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1977; 1: 131-143.
18. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 1970; 172: 902-908.
19. Måsbäck A, Westerdahl J, Ingvar C, et al. Cutaneous malignant melanoma in Southern Sweden 1965, 1975 and 1985. Prognostic factors and histologic correlations. Cancer 1997; 79: 2.75-283.
20. MacKie RM, Aitchison T. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland. Br J Cancer 1982; 46: 955-960.
21. Greene MH, Clark WH, Tucker MA, et al. High risk of malignant melanoma in melanoma-prone families with dysplastic nevi. Ann Intern Med 1985; 102: 458-465.
22. Bain C, Colditz GA, Willett WC, et al. Self-reports of mole counts and cutaneous malignant melanoma in women: methodological issues and risk of disease. Am J Epidemiol 1988; 127: 703-712.
23. Gruber SB, Roush GC, Barnhill RL. Sensitivity and specificity of self examination for cutaneous malignant melanoma risk factors. Am J Prev Med 1993; 9: 50-54.
24. Stierner U, Augustsson A, Rosdahl I, et al. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. Melanoma Res 1991; 1: 367-375.
25. Carey WP Jr, Thompson CJ, Synnestvedt M, et al. Dysplastic nevi as melanoma risk factor in patients with familial melanoma. Cancer 1994; 74: 3118-3125.
26. Piepkorn MW, Barnhill RL, Cannon-Albright LA, et al. A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol 1994; 30: 707-714.
27. Kopf AW, Hellman LJ, Rogers GS, et al. Familial malignant melanoma. JAMA 1986; 256: 1915-1919.
28. Duke D, Castresana J, Lucchina L, et al. Familial cutaneous melanoma and two-mutational-event modeling. Cancer 1993; 72: 3239-3243.
29. Lucchina LC, Barnhill RL, Duke DM, et al. Familial cutaneous melanoma. Melanoma Res 1995; 5: 413-418.
30. Knudson AG Jr. Heredity and human cancer. Am J Pathol 1974; 77: 77-84.
31. Aitken JF, Duffy DL, Green A, et al. Heterogeneity of melanoma risk in families of melanoma patients. Am J Epidemiol 1994; 140: 961-973.
32. Augustsson A, Stierner U, Rosdahl I, et al. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Dermatovenerol 1991; 71: 512-517.